Rocket Pharmaceuticals, Inc.

DB:9IP1 Stock Report

Market Cap: €1.2b

Rocket Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:9IP1 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
21 Nov 24Sell€138,021Gaurav ShahIndividual11,091€12.44
21 Nov 24Sell€14,622Martin WilsonIndividual1,175€12.44
21 Nov 24Sell€15,232John MilitelloIndividual1,224€12.44
21 Nov 24Sell€57,095Kinnari PatelIndividual4,588€12.44
31 Oct 24Sell€14,041John MilitelloIndividual917€15.31
31 Oct 24Sell€47,160Mark WhiteIndividual3,080€15.31
16 Aug 24Sell€67,155Kinnari PatelIndividual3,989€16.83
16 Aug 24Sell€17,289Martin WilsonIndividual1,027€16.83
16 Aug 24Sell€162,457Gaurav ShahIndividual9,650€16.83
16 Aug 24Sell€17,912John MilitelloIndividual1,064€16.83
22 Jul 24Sell€17,171John MilitelloIndividual812€21.15
08 Jul 24Sell€56,963Mark WhiteIndividual3,026€18.82
16 May 24Sell€22,513Martin WilsonIndividual1,048€21.48
16 May 24Sell€23,179John MilitelloIndividual1,079€21.48
16 May 24Sell€86,916Kinnari PatelIndividual4,046€21.48
16 May 24Sell€210,309Gaurav ShahIndividual9,790€21.48
22 Apr 24Sell€17,898John MilitelloIndividual833€21.49
15 Apr 24Sell€226,209David SouthwellIndividual10,000€22.62
08 Apr 24Sell€284,433Mark WhiteIndividual12,532€22.70
21 Mar 24Sell€64,444John MilitelloIndividual2,490€25.88
21 Mar 24Sell€7,174,680Simran Investment Group LlcCompany274,000€26.18
29 Feb 24Sell€111,250Martin WilsonIndividual4,100€27.13
16 Feb 24Sell€561,446Gaurav ShahIndividual20,272€27.70
16 Feb 24Sell€89,678John MilitelloIndividual3,238€27.70
16 Feb 24Sell€99,040Martin WilsonIndividual3,576€27.70
16 Feb 24Sell€197,525Kinnari PatelIndividual7,132€27.70
22 Jan 24Sell€15,938John MilitelloIndividual638€24.98

Insider Trading Volume

Insider Buying: 9IP1 insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 9IP1?
Owner TypeNumber of SharesOwnership Percentage
Private Companies104,9270.106%
Individual Insiders2,282,5312.31%
Hedge Funds17,687,77217.9%
Institutions78,580,28979.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 84.1% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.4%
RTW Investments, LP
17,687,772€236.2m0%3.35%
12.3%
Wellington Management Group LLP
11,242,144€150.1m22.8%0.02%
6.99%
BlackRock, Inc.
6,370,721€85.1m2.88%no data
6.07%
The Vanguard Group, Inc.
5,536,940€73.9m-4.68%no data
4.93%
Westfield Capital Management Company, L.P.
4,493,833€60.0m3.83%0.26%
4.52%
Maverick Capital, Ltd.
4,118,672€55.0m4.85%1.04%
3.52%
T. Rowe Price Group, Inc.
3,207,781€42.8m1.21%no data
3.4%
State Street Global Advisors, Inc.
3,102,022€41.4m11.6%no data
2.36%
Citadel Advisors LLC
2,148,093€28.7m-23.8%0.03%
2.08%
Janus Henderson Group plc
1,897,340€25.3m-35%0.01%
1.77%
Geode Capital Management, LLC
1,617,866€21.6m0.89%no data
1.63%
Frazier Life Sciences Management, LP
1,485,630€19.8m-4.84%0.83%
1.61%
Tavistock Life Sciences
1,466,051€19.6m0%1.31%
1.52%
Pictet Asset Management Limited
1,386,705€18.5m13.1%0.02%
1.32%
Millennium Management LLC
1,202,495€16.1m1,040%0.01%
1.22%
Gaurav Shah
1,113,566€14.9m-0.99%no data
1.21%
Novo Holdings A/S
1,100,000€14.7m0%0.01%
1.21%
Cowen Inc,Private Banking and Investment Banking Investments
1,100,000€14.7m0%0.43%
1.17%
BioImpact Capital LLC
1,066,373€14.2m0%2.36%
1.06%
Franklin Resources, Inc.
969,547€12.9m-13.2%no data
1.02%
Perceptive Advisors LLC
931,851€12.4m-25.3%0.28%
1%
Dimensional Fund Advisors LP
912,605€12.2m-3.55%no data
0.97%
Baron Capital Group, Inc.
884,341€11.8m-9.7%0.03%
0.89%
Russell Investment Management, LLC
812,310€10.8m19.9%0.01%
0.89%
Medical Strategy GmbH, Asset Management Arm
808,816€10.8m0%0.67%